Clinical indicators of adrenal insufficiency following discontinuation of oral glucocorticoid therapy: A Danish population-based self-controlled case series analysis
Open accessThe DOI matches its Crossref record; 29 of the 29 references it cites were found in a registry or an index.
Abstract
BACKGROUND: Biochemical adrenal insufficiency induced by glucocorticoid treatment is prevalent, but data on the clinical implications are sparse. We investigated clinical consequences of glucocorticoid-induced adrenal insufficiency after oral glucocorticoid cessation. METHODS: We conducted a Danish population-based self-controlled case series utilizing medical registries. In this design each individual serves as their own control allowing event rates to be compared as a function of time and treatment. Clinical indicators of adrenal insufficiency were defined as diagnoses of gastrointestinal symptoms, hypotension, cardiovascular collapse, syncope, hyponatremia, and hypoglycaemia. We included 286,680 persons who discontinued long-term (≥ 3 months) oral glucocorticoid treatment. We defined five risk periods and a reference period (before treatment): period 0 (on treatment), withdrawal period (1 month before and after cessation), followed by three consecutive 2 month-risk periods after withdrawal (periods 2-4). RESULTS: Median age at cessation was 69 years and 57% were female. Median treatment duration was 297 days and median cumulative dose was 3000 mg prednisolone equivalents. The incidence rates of hypotension, gastrointestinal symptoms, hypoglycemia and hyponatremia were increased in the withdrawal period compared to before treatment started (reference period). Incidence rate ratios comparing the withdrawal period with the reference period were 2.5 [95% confidence interval (CI): 1.4-4.3] for hypotension, 1.7 (95% CI: 1.6-1.9) for gastrointestinal symptoms, 2.2 (95% CI: 0.7-7.3) for hypoglycemia, and 1.5 (95% CI: 1.1-2.0) for hyponatremia. During 7 months of follow up, the rates of hypotension and gastrointestinal symptoms remained elevated compared to the reference period. Risk factors included use of antibiotics, increasing average daily dose of glucocorticoids, cumulative dose, and age. CONCLUSION: Oral glucocorticoid withdrawal was associated with adverse outcomes attributable to adrenal insufficiency. Our study underscores the need for future research to establish evidence-based clinical guidance on management of patients who discontinue oral glucocorticoids.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures



Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“diagnosis is often delayed [10][11][12][13]”
From Home waking salivary cortisone to screen for adrenal insufficiency (2023) · cites this paper as [11]
Experimental — accuracy not yet measuredThe cited source says what the claim attributes to it.
In the citing paper
“A Danish self-controlled case series including 286 680 persons who discontinued prolonged (≥3 months) oral glucocorticoid treatment, assessed the presence of clinical consequences of glucocorticoid-induced adrenal insufficiency after glucocorticoid cessation (25).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“A population-based study found an increased incidence of potential manifestations of untreated adrenal insufficiency (hypotension, gastrointestinal symptoms, hypoglycemia, and hyponatremia) after discontinuation of long-term oral glucocorticoids (25).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“Individuals exposed to infections—common triggers of adrenal insufficiency symptoms—and older individuals taking higher glucocorticoid doses for longer periods prior to discontinuation carried a higher risk of developing these manifestations (25).”
From European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: Diagnosis and Therapy of Glucocorticoid-induced Adrenal Insufficiency (2024) · cites this paper as [25]
The cited source says what the claim attributes to it.
In the citing paper
“The symptoms of AI occur more frequently within a few weeks after glucocorticoid withdrawal, although hypotension, gastrointestinal discomfort, and hypoglycemia may persist several months after withdrawal (18).”
From The Changing Face of Drug-induced Adrenal Insufficiency in the Food and Drug Administration Adverse Event Reporting System (2022) · cites this paper as [18]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sapolsky, R. M., Romero, L. M., & Munck, A. U. (2000) · Endocrine Reviews · doi:10.1210/edrv.21.1.0389 · Cited by 7,541 · cited 3×
“In addition, persons exposed to an infection (potential stressor) were also at increased risk of clinical adrenal insufficiency, which fits well with the underlying pathophysiology of cortisol deficiency [7].”
BackgroundInfluentialSapolsky, R. M. (2000) · Endocrine Reviews · doi:10.1210/er.21.1.55 · Cited by 7,533
The Danish National Patient Registry: a review of content, data quality, and research potential
Schmidt, M., Schmidt, S. A. J., Sandegaard, J. L., Ehrenstein, V., Pedersen, L., & Sørensen, H. T. (2015) · Clinical Epidemiology · doi:10.2147/clep.s91125 · Cited by 4,769 · cited 4×
“Tenth Revision of the International Classification of Diseases (ICD-10) codes for outcome events.”
ResultInfluentialSelf-citationThe Danish Civil Registration System as a tool in epidemiology
Schmidt, M., Pedersen, L., & Sørensen, H. T. (2014) · European Journal of Epidemiology · doi:10.1007/s10654-014-9930-3 · Cited by 3,441 · cited 1×
“assigned to all Danish residents at birth or upon immigration, enabling accurate and unambiguous individual-level linkage of relevant registries [24].”
BackgroundSelf-citationEndocrinology of the stress response
Charmandari, E., Tsigos, C., & Chrousos, G. (2005) · Annual Review of Physiology · doi:10.1146/annurev.physiol.67.040403.120816 · Cited by 1,799
Data Resource Profile: The Danish National Prescription Registry
Pottegård, A., Schmidt, S. A. J., Wallach-Kildemoes, H., Sørensen, H. T., Hallas, J., & Schmidt, M. (2016) · International Journal of Epidemiology · doi:10.1093/ije/dyw213 · Cited by 1,431 · cited 1×
“We used the Danish National Prescription Registry [25] (DNPR) to identify all persons who discontinued long-term (� 3 months) treatment with oral glucocorticoids between January 1, 1996 and December 31, 2014 [26].”
MethodSelf-citationWaljee, A. K., Rogers, M. A. M., Lin, P., Singal, A. G., Stein, J. D., Marks, R. M., Ayanian, J. Z., & Nallamothu, B. K. (2017) · BMJ · doi:10.1136/bmj.j1415 · Cited by 830 · cited 1×
“We then used a self-controlled case series design [22, 23], in which each individual served as their own control and adverse event rates during and after glucocorticoid treatment were compared to a reference period.”
MethodArlt, W., & Allolio, B. (2003) · The Lancet · doi:10.1016/s0140-6736(03)13492-7 · Cited by 819 · cited 2×
“The following putative clinical indicators of adrenal insufficiency were identified in the Danish National Patient Registry (DNPR): hypotension, syncope, cardiovascular collapse, hyponatremia, hypoglycemia, and gastrointestinal symptoms [1].”
BackgroundTutorial in biostatistics: the self‐controlled case series method
Whitaker, H. J., Paddy Farrington, C., Spiessens, B., & Musonda, P. (2006) · Statistics in Medicine · doi:10.1002/sim.2302 · Cited by 719 · cited 1×
“We estimated incidence rate ratios (IRRs) using the self-controlled case series design [22, 28].”
MethodCharmandari, E., Nicolaides, N. C., & Chrousos, G. P. (2014) · The Lancet · doi:10.1016/s0140-6736(13)61684-0 · Cited by 644
Self controlled case series methods: an alternative to standard epidemiological study designs
Petersen, I., Douglas, I., & Whitaker, H. (2016) · BMJ · doi:10.1136/bmj.i4515 · Cited by 525 · cited 4×
“We then used a self-controlled case series design [22, 23], in which each individual served as their own control and adverse event rates during and after glucocorticoid treatment were compared to a reference period.”
BackgroundMethodInfluentialSelf-citationAdrenal insufficiency in corticosteroids use: systematic review and meta-analysis
Broersen, L. H. A., Pereira, A. M., Jørgensen, J. O. L., & Dekkers, O. M. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2015-1218 · Cited by 456
Self-citationPredisposing Factors for Adrenal Insufficiency
Bornstein, S. R. (2009) · New England Journal of Medicine · doi:10.1056/nejmra0804635 · Cited by 356
Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment
Henzen, C., Suter, A., Lerch, E., Urbinelli, R., Schorno, X. H., & Briner, V. A. (2000) · The Lancet · doi:10.1016/s0140-6736(99)06290-x · Cited by 290
Glucocorticoid-induced adrenal insufficiency
Krasner, A. S. (1999) · JAMA · doi:10.1001/jama.282.7.671 · Cited by 197
Adrenal Corticosteroid Biosynthesis, Metabolism, and Action
Arlt, W., & Stewart, P. M. (2005) · Endocrinology and Metabolism Clinics of North America · doi:10.1016/j.ecl.2005.01.002 · Cited by 195
Systemic glucocorticoid therapy and adrenal insufficiency in adults: a systematic review
Joseph, R. M., Hunter, A. L., Ray, D. W., & Dixon, W. G. (2016) · Seminars in Arthritis and Rheumatism · doi:10.1016/j.semarthrit.2016.03.001 · Cited by 179 · cited 3×
“In general, high dose and longer treatment duration have been associated with higher adrenal insufficiency risk [4, 5].”
BackgroundWoods, C. P., Argese, N., Chapman, M., Boot, C., Webster, R., Dabhi, V., Grossman, A. B., Toogood, A. A., Arlt, W., Stewart, P. M., et al. (2015) · European Journal of Endocrinology · doi:10.1530/eje-15-0608 · Cited by 152 · cited 1×
“It is well known that use of other glucocorticoid formulations, such as inhaled and injectable forms and glucocorticoids acting on the intestine, also increases the risk of iatrogenic adrenal insufficiency [29, 30].”
BackgroundADRENAL SUPPRESSION AFTER SHORT-TERM CORTICOSTEROID THERAPY
Rj, S., Oliff, A., Bruton, J., Vigersky, R., Echelberger, C. K., & Poplack, D. (1979) · The Lancet · doi:10.1016/s0140-6736(79)91077-8 · Cited by 107
Adrenal axis function after high‐dose steroid therapy for childhood acute lymphoblastic leukemia
Einaudi, S., Bertorello, N., Masera, N., Farinasso, L., Barisone, E., Rizzari, C., Corrias, A., Villa, A., Riva, F., Saracco, P., et al. (2008) · Pediatric Blood & Cancer · doi:10.1002/pbc.21339 · Cited by 91
How to avoid precipitating an acute adrenal crisis
Wass, J. A. H., & Arlt, W. (2012) · BMJ · doi:10.1136/bmj.e6333 · Cited by 61 · cited 1×
“It is well known that use of other glucocorticoid formulations, such as inhaled and injectable forms and glucocorticoids acting on the intestine, also increases the risk of iatrogenic adrenal insufficiency [29, 30].”
BackgroundSystemic glucocorticoid use in Denmark: a population-based prevalence study
Laugesen, K., Jørgensen, J. O. L., Sørensen, H. T., & Petersen, I. (2017) · BMJ Open · doi:10.1136/bmjopen-2016-015237 · Cited by 61 · cited 1×
“This is noteworthy, considering that the annual prevalence of systemic glucocorticoid use is 3% in the Danish population [16].”
BackgroundSelf-citationJamilloux, Y., Liozon, E., Pugnet, G., Nadalon, S., Heang Ly, K., Dumonteil, S., Gondran, G., Fauchais, A.-L., & Vidal, E. (2013) · PLoS ONE · doi:10.1371/journal.pone.0068713 · Cited by 59
Rix, M., Birkebæk, N., Rosthøj, S., & Clausen, N. (2005) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2005.06.006 · Cited by 54
Hypothalamic-pituitary-adrenal function one week after a short burst of steroid therapy
Carella, M. J. (1993) · Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.76.5.1188 · Cited by 41 · cited 1×
“Prior randomized controlled trials [9, 10] (range: n = 10–42 included persons) and cohort studies [11–15] (range: n = 10–150 persons included) Fig 3.”
Background(1986) · QJM: An International Journal of Medicine · doi:10.1093/oxfordjournals.qjmed.a068059 · Cited by 28
Risk of adrenal insufficiency with steroid maintenance therapy in renal transplantation
Boots, J. M. M., van den Ham, E. C. H., Christiaans, M. H. L., & van Hooff, J. P. (2002) · Transplantation Proceedings · doi:10.1016/s0041-1345(02)02987-1 · Cited by 24 · cited 1×
“Prior randomized controlled trials [9, 10] (range: n = 10–42 included persons) and cohort studies [11–15] (range: n = 10–150 persons included) Fig 3.”
BackgroundThe effect of a steroid “burst” and long-term, inhaled fluticasone propionate on adrenal reserve
Nguyen, K.-L., Lauver, D., Kim, I., & Aresery, M. (2003) · Annals of Allergy, Asthma & Immunology · doi:10.1016/s1081-1206(10)62056-x · Cited by 20
Laugesen, K., Støvring, H., Hallas, J., Pottegård, A., Jørgensen, J. O. L., Sørensen, H. T., & Petersen, I. (2017) · Clinical Epidemiology · doi:10.2147/clep.s148671 · Cited by 5 · cited 1×
“We used the Danish National Prescription Registry [25] (DNPR) to identify all persons who discontinued long-term (� 3 months) treatment with oral glucocorticoids between January 1, 1996 and December 31, 2014 [26].”
MethodSelf-citation
Cited by
Glucocorticoid induced adrenal insufficiency
Prete, A., & Bancos, I. (2021) · BMJ · doi:10.1136/bmj.n1380 · Cited by 155
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/clinem/dgae250 · Cited by 172
Beuschlein, F., Else, T., Bancos, I., Hahner, S., Hamidi, O., van Hulsteijn, L. T., Husebye, E. S., Karavitaki, N., Prete, A., Vaidya, A., et al. (2024) · European Journal of Endocrinology · doi:10.1093/ejendo/lvae029 · Cited by 156
Home waking salivary cortisone to screen for adrenal insufficiency
Debono, M., Elder, C. J., Lewis, J., Fearnside, J., Caunt, S., Dixon, S., Jacques, R. M., Newell-Price, J., Whitaker, M. J., Keevil, B., et al. (2023) · NEJM Evidence · doi:10.1056/evidoa2200182 · Cited by 66
Gurnell, M., Heaney, L. G., Price, D., & Menzies-Gow, A. N. (2021) · Journal of Internal Medicine · doi:10.1111/joim.13273 · Cited by 51
Metadata
- Authors
- Laugesen, K., Petersen, I., Sørensen, H. T., & Jørgensen, J. O. L.
- Affiliations
- Aarhus University Hospital (DK)
- Corresponding author
- Laugesen, Kristina
- Venue
- PLoS ONE
- Publisher
- Public Library of Science (PLoS)
- Published
- 2019-02-19
- Volume
- 14
- Issue
- 2
- Pages
- e0212259
- ISSN
- 1932-6203 (ISSN-L)
- PMC
- PMC6380588
- OpenAlex
- W2915920111
- Cited by
- 30
- References
- 28
- Citations by year
- 2026: 1 · 2025: 5 · 2024: 8 · 2023: 6 · 2022: 4 · 2021: 4 · 2020: 2
- FWCI
- 2.03
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- Locations
- PLoS ONE (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- UCL Discovery (University College London) (submittedVersion)
- Figshare (submittedVersion, cc-by)
- Funders
- Aarhus Universitet
- Aarhus Universitets Forskningsfond
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adrenal Hormones and Disorders
- Life Sciences › Neuroscience › Behavioral Neuroscience › Stress Responses and Cortisol
- Health Sciences › Medicine › Nephrology › Electrolyte and hormonal disorders
- Keywords
- glucocorticoid-induced adrenal insufficiency, glucocorticoid discontinuation, hypotension, gastrointestinal symptoms, hypoglycemia, hyponatremia, cardiovascular collapse, syncope, cumulative glucocorticoid dose, risk factors
- MeSH terms
- Administration, Oral, Adolescent, Adrenal Insufficiency, Adult, Aged, Aged, 80 and over, Child, Child, Preschool, Denmark, Female, Glucocorticoids, Humans, Infant, Infant, Newborn, Male, Middle Aged, Prednisolone, Registries, Self Report
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.